Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-0842-03
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Weekly Versus Three Weeks Chemotherapy for Advanced Ovarian Cancer: A Meta-Analysis

Oncotarget
Oncology
2016English

Weekly Docetaxel for Outpatients With Head and Neck Cancer

Japanese jornal of Head and Neck Cancer
2004English

Comparative Study of Weekly and Three Weekly Chemoradiation Regimen in Advanced Head and Neck Cancer at Silchar Medical College

International Journal of Science and Research (IJSR)
2017English

Weekly Docetaxel in the Treatment of Metastatic Breast Cancer

Therapeutics and Clinical Risk Management
2008English

Epoetin Alfa 60,000 U Once Weekly Followed by 120,000 U Every 3 Weeks Increases and Maintains Hemoglobin Levels in Anemic Cancer Patients Undergoing Chemotherapy

Oncologist
Cancer ResearchMedicineOncology
2004English

Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Urology
Urology
2008English

Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2010English

Influence of Garlic (Allium Sativum) on the Pharmacokinetics of Docetaxel

Clinical Cancer Research
Cancer ResearchOncology
2006English

Complete Eradication of De-Differentiated Skin Recurrence of Papillary Thyroid Carcinoma With Weekly Docetaxel

International Cancer Conference Journal
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy